Fidest – Agenzia giornalistica/press agency

Quotidiano di informazione – Anno 33 n° 335

John Amatruda, MD, and Philip Lambert, PhD, Join Life Biosciences

Posted by fidest press agency su venerdì, 19 ottobre 2018

Life Biosciences Inc. announced today the appointment of two renowned scientists to senior positions at the pioneering company. Dr. John Amatruda has been appointed president of Life Laboratories, which provides central management and resources for drug discovery and development across Life Biosciences and its Daughter companies. Philip Lambert, PhD, has been named senior vice president, discovery and laboratories at Life Biosciences. Dr. Amatruda is also a member of Life Biosciences’ Scientific Advisory Board.Life Biosciences is the first and largest company to address age-related decline (ARD) as a systemic breakdown of the body, rather than a series of isolated events and conditions. The two scientists will support all Life Biosciences’ Daughter companies, as they pursue their independent and collaborative research into the eight pathways of age-related decline.
“We are thrilled and privileged to have John and Phil on our team,” said Tristan Edwards, co-founder and chief executive officer of Life Biosciences. “Their exceptional and celebrated experience in both drug discovery and company-building will make them invaluable contributors to our mission.”Throughout his 26-year career in drug research and development, Dr. Amatruda has produced drugs that treat diabetes and cardiovascular disease. In addition to tenures as a professor at Yale University School of Medicine and The University of Rochester School of Medicine, he co-founded the biotech company CohBar, served on numerous scientific advisory panels and boards of directors and was a Vice President at Bayer Corp. and a Senior Vice President at Merck Pharmaceuticals.Dr. Lambert brings more than 25 years of experience in drug discovery and development to his role at Life Biosciences, as well as remarkable expertise in building companies and providing efficient and predictive preclinical drug discovery. Dr. Lambert comes to Life Biosciences from Charles River Laboratories where he was Head of Discovery Labs. Previously, Dr. Lambert co-founded and was Chief Scientific Officer at VivoPath, a contract research organization providing drug discovery solutions to the pharmaceutical and biotechnology community. Dr. Lambert brings a diverse perspective to his role at Life having held positions in biotechnology, large pharmaceutical companies, a non-profit, and contract research organizations.

Rispondi

Inserisci i tuoi dati qui sotto o clicca su un'icona per effettuare l'accesso:

Logo di WordPress.com

Stai commentando usando il tuo account WordPress.com. Chiudi sessione /  Modifica )

Google photo

Stai commentando usando il tuo account Google. Chiudi sessione /  Modifica )

Foto Twitter

Stai commentando usando il tuo account Twitter. Chiudi sessione /  Modifica )

Foto di Facebook

Stai commentando usando il tuo account Facebook. Chiudi sessione /  Modifica )

Connessione a %s...

 
%d blogger hanno fatto clic su Mi Piace per questo: